We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Senate Finance Committee Chairman Chuck Grassley (R-Iowa) and ranking member Ron Wyden (D-Ore.) have updated their bipartisan drug pricing legislation with provisions to reduce out-of-pocket expenses — and President Trump has said he would sign it into law. Read More
Four high-ranking House Republicans introduced drug pricing legislation Monday designed to replace House Speaker Nancy Pelosi’s H.R. 3, a bill they dismissed as one-sided and doomed to fail. Read More
The agency warned sponsors that recent technological innovations make it easy for other parties to easily deduce a patient’s identity from deidentified trial data. Read More
Acting FDA Commissioner Brett Giroir said the biosimilar and interchangeable insulin products should increase access and reduce costs of insulin products. Read More